Novavax: green light for Covid vaccine in the UK
' Today's authorization by the MHRA is recognition of the role our vaccine can play in protecting the British public against Covid-19 this year,' said John C. Jacobs, President and CEO of Novavax.
The approval is based on non-clinical data showing that Novavax's updated vaccine induces functional immune responses for the XBB.1.5, XBB.1.16 and XBB.2.3 variants.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction